Compare HGV & INSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HGV | INSP |
|---|---|---|
| Founded | 1992 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Hotels/Resorts | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 2.2B |
| IPO Year | 2017 | 2018 |
| Metric | HGV | INSP |
|---|---|---|
| Price | $43.97 | $61.21 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 11 | 18 |
| Target Price | $47.70 | ★ $69.63 |
| AVG Volume (30 Days) | ★ 1.3M | 595.0K |
| Earning Date | 10-29-2026 | 11-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 97.78 | ★ 179.43 |
| EPS | ★ 4.54 | N/A |
| Revenue | ★ $5,047,000,000.00 | $82,050,000.00 |
| Revenue This Year | $15.87 | N/A |
| Revenue Next Year | N/A | $2.61 |
| P/E Ratio | $9.65 | ★ N/A |
| Revenue Growth | 1.33 | ★ 62.18 |
| 52 Week Low | $33.99 | $38.91 |
| 52 Week High | $55.40 | $147.03 |
| Indicator | HGV | INSP |
|---|---|---|
| Relative Strength Index (RSI) | 68.78 | 36.71 |
| Support Level | $43.80 | $60.10 |
| Resistance Level | $50.08 | $63.20 |
| Average True Range (ATR) | 1.81 | 2.72 |
| MACD | 0.56 | -0.86 |
| Stochastic Oscillator | 84.85 | 9.14 |
Hilton Grand Vacations Inc is a timeshare company engaged in developing, marketing, selling, managing, and operating timeshare resorts and timeshare plans under the Hilton Grand Vacations brand. The company operates in two segments: Real estate sales and financing, and Resort operations and club management. The Real estate sales and financing segment generates revenue from VOI sales and consumer financing, including interest income from loans to members. The Resort operations and club management segment generates revenue from resort management services, club membership fees, and rental of available inventory. The majority of the company's revenue is earned through the Real estate sales and financing segment.
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and All other countries wherein, it generates a majority of its revenue from the United States. Its segment revenues are derived from the sales of its product, the Inspire system, to hospitals and ambulatory surgery centers in the U.S. and in selected countries in Europe and the Asia Pacific region.